Anti-platelet or anti-coagulant agent for the prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation - A nation-wide database analyses

International Journal of Cardiology

Volumn 177, Issue 3, 2014, Pages 1008-1011

  Chen, Jien Jiun ^a   Lin, Lian Yu ^a   Yang, Yao Hsu ^b,c   Hwang, Juey Jen ^a   Chen, Pau Chung ^b   Lin, Jiunn Lee ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Atrial fibrillation; End stage renal disease; Stroke; Warfarin

Indexed keywords

ANTITHROMBOCYTIC AGENT; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROPENSITY SCORE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; TAIWAN;

EID: 84920028036     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.09.140     Document Type: Article

References (27)

1. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, and J.V. Selby Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370 2375
2. K.L. Chien, T.C. Su, H.C. Hsu, W.T. Chang, P.C. Chen, and M.F. Chen Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese Int J Cardiol 139 2010 173 180
3. G.Y. Lip, H.F. Tse, and D.A. Lane Atrial fibrillation Lancet 379 2012 648 661
4. R.H. Falk Atrial fibrillation N Engl J Med 344 2001 1067 1078
5. A. Pieri, T.O. Lopes, and A.A. Gabbai Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation Int J Stroke 6 2011 466
6. D. Zimmerman, M.M. Sood, C. Rigatto, R.M. Holden, S. Hiremath, and C.M. Clase Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis Nephrol Dial Transplant 27 2012 3816 3822
7. J. Danziger Vitamin K-dependent proteins, warfarin, and vascular calcification Clin J Am Soc Nephrol 3 2008 1504 1510
8. M. Shah, M. Avgil Tsadok, C.A. Jackevicius, V. Essebag, M.J. Eisenberg, and E. Rahme Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis Circulation 129 2014 1196 1203
9. K.E. Chan, J.M. Lazarus, R. Thadhani, and R.M. Hakim Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation J Am Soc Nephrol 20 2009 2223 2233
10. I. Sabir, K. Khavandi, J. Brownrigg, and A.J. Camm Oral anticoagulants for Asian patients with atrial fibrillation Nat Rev Cardiol 11 2014 290 303
11. S. Liao, T. Woulfe, S. Hyder, E. Merriman, D. Simpson, and S. Chunilal Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study J Thromb Haemost 12 2014 214 219
12. W.S. Lee, K.I. Kim, H.J. Lee, H.S. Kyung, and S.S. Seo The incidence of pulmonary embolism and deep vein thrombosis after knee arthroplasty in Asians remains low: a meta-analysis Clin Orthop Relat Res 471 2013 1523 1532
13. J.F. Lu, and W.C. Hsiao Does universal health insurance make health care unaffordable? Lessons from Taiwan Health Aff (Millwood) 22 2003 77 88
14. T.L. Chiang Taiwan's 1995 health care reform Health Policy 39 1997 225 239
15. C.H. Tseng Mortality and causes of death in a national sample of diabetic patients in Taiwan Diabetes Care 27 2004 1605 1609
16. H.F. Chen, C.A. Ho, and C.Y. Li Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients Diabetes Care 29 2006 2409 2414
17. W.C. Winkelmayer, A.R. Patrick, J. Liu, M.A. Brookhart, and S. Setoguchi The increasing prevalence of atrial fibrillation among hemodialysis patients J Am Soc Nephrol 22 2011 349 357
18. E. De Beus, R. De Jager, J.A. Joles, G. Grassi, and P.J. Blankestijn Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation? J Hypertens 32 9 2014 1751 1761
19. S.E. Nelson, G.R. Shroff, S. Li, and C.A. Herzog Impact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in medicare patients J Am Heart Assoc 1 2012 e002097
20. M.S. Buiten, M.K. De Bie, J.I. Rotmans, B.A. Gabreels, W. van Dorp, and R. Wolterbeek The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients Heart 100 2014 685 690
21. C.A. Herzog, R.W. Asinger, A.K. Berger, D.M. Charytan, J. Diez, and R.G. Hart Cardiovascular disease in chronic kidney disease. A clinical update from kidney disease: improving global outcomes (KDIGO) Kidney Int 80 2011 572 586
22. C.T. January, L.S. Wann, J.S. Alpert, H. Calkins, JC Cleveland Jr., and J.E. Cigarroa AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 2014 2014
23. C.B. Granger, and G.M. Chertow A pint of sweat will save a gallon of blood: a call for randomized trials of anticoagulation in end-stage renal disease Circulation 129 2014 1190 1192
24. http://anticoagulation.cardiosource.org/Hot-Topics/2014/05/Anticoagulation-for-Stroke-Prophylaxis-in-AFib-Patients.aspx [accessed July 27, 2014]
25. S. Mantha, and J. Ansell An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation Thromb Haemost 108 2012 476 484
26. M.M. Ciccone, F. Cortese, F. Corbo, N.E. Corrales, A.K. Al-Momen, and A. Silva Bemiparin, an effective and safe low molecular weight heparin: a review Vascul Pharmacol 62 2014 32 37
27. A.R. Assaf, K.L. Lapane, J.L. McKenney, and R.A. Carleton Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease N Engl J Med 329 1993 931 935